A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE4
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- Status
- RECRUITING
- Phase
- PHASE4
GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL
- Status
- RECRUITING
- Phase
- PHASE1
Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Status
- RECRUITING
- Phase
- PHASE2
Epco, Zanu, Ritux for R/R FL or MZL
- Status
- RECRUITING
- Phase
- PHASE2
Vitamin A and D Supplementation in Allogeneic HCT
- Status
- RECRUITING
- Phase
- PHASE2
Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
- Status
- RECRUITING
- Phase
- PHASE1
CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab
- Status
- RECRUITING
- Phase
- PHASE1
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
- Status
- RECRUITING
- Phase
- N/A
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PTCy and ATG for MSD and MUD Transplants
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
- Status
- RECRUITING
- Phase
- EARLY_PHASE1